News


All News

Erythematotelangiectatic rosacea, characterized by diffuse and persistent facial redness and telangiectasias, is a challenging disease to treat. Recent advances in laser and light therapies appear effective in improving these symptoms.

Survival rates for lentigo maligna (LM) melanoma-type melanomas vary. Acral lentiginous melanoma has a significantly worse survival rate than other melanoma subtypes with race appearing to play a role. Another factor may be poor awareness.

Treating troublesome IH early can help avoid or minimize complications, but complex requirements demand that physicians and parents cultivate strong relationships and effective communication.

Even when quality-of-care concerns prompt physicians to advocate on behalf of family members, navigating the medical system can be challenging and fraught with difficulty.

Depending on your circumstances you could save tens of thousands of dollars on your 2015 income tax bill. Lear how

A 7-year-old girl is brought into the office for evaluation of eczema. On review of symptoms, her mother mentions concern about a bald spot above the daughter's right ear, noticeable when she braids her hair.

Gain an international perspective on the use of fillers and toxins, the latest advances in non-invasive techniques and technologies, and learn from a state-of-the-art practice management track that will offer business tips, marketing/branding ideas and website and social media best practices.

Applications and nominations for several awards are being accepted now for dermatologists to receive recognition for thier work during the upcoming American Academy of Dermatology annual meeting.

Clinicians agree that multi-disciplinary teams are the optimal approach to managing advanced melanoma, for they aim for consistent messaging to patients about treatment and require that physicians who are members of the team support their therapeutic choices with evidence. However, obstacles include geographical challenges in community care, treatment sequencing and bias, and physician communication.

Dermatology Times editorial advisor Dr. Elaine Siegfried talks with Jim Leyden, M.D., emeritus professor of dermatology at the University of Pennsylvania about the art and science of isotretinoin therapy. Dr. Leyden, aside from being a member of the famed Acne Mafia, was a really active participant in the drug development process for isotretinoin, a drug for which, the institutional memory about that process may be fading. The two discuss many of the important initial clinical observations and those that others have made over the years.

Accruing and forthcoming data are being looked to for guidance on the best strategies for implementing these treatments. As valued members of the multidisciplinary care team for patients with metastatic melanoma, dermatologists should keep informed about these topics.

A recent study has shed some light on the genetic predisposition of rosacea as well as other associated environmental factors, which could lead to improved treatment and management of the disease.

Because skin malignancies often herald internal or systemic malignancies, knowing the link between primary and metastatic sites can impact staging, prognosis and management – and in some cases, save lives.

Key issues with fillers for the hands include avoiding overfilling and informing patients about the likelihood of post-injection swelling.

Rx insurance woes

Do your patients think their insurance covers all medications? Get answers.

Immunosuppressed patient with recurrent squamous cell carcinoma succumbs to death. Was the dermatologist who did his skin evaluations negligent?

Your cosmetic consultant should fit your practice, represent your ideals, understand the industry and procedures, and feel comfortable discussing prices with patients. Four experts offer insight on their consult best practices.